Boeing's 737 Max 10 approved for passenger service after years of delays: FAA says

The FAA approved Boeing’s 737 Max 10 design after years of delays, completing certification of the four-model 737 Max lineup and allowing the aircraft to be sold to carriers. Boeing now expects first deliveries in 2027, versus its 2020 estimate of 2023; CEO Kelly Ortberg said the Max 10 represents roughly 30% of Boeing’s 737 backlog, while the company lists more than 4,500 total 737 aircraft on backlog. Each aircraft still requires clearance before carrying passengers, and Boeing must demonstrate it can consistently build to the approved design.

Analysis

Certification removes a meaningful program-level overhang for Boeing (BA), but it does not convert the Max 10 backlog into near-term cash: deliveries are still expected to start in 2027, and production consistency plus clearance of each aircraft remain gating items. The key value driver shifts from regulatory approval to execution—whether Everett can add output without disrupting other 737 production or exposing Boeing to renewed quality scrutiny. The reported backlog share makes execution important, but backlog is not equivalent to firm, economically attractive deliveries; verify customer commitments, delivery timing and any compensation or deferral terms.

Airbus (AIR) retains the product advantage where range and capacity matter, so certification narrows Boeing’s competitive gap rather than reversing it. For airlines, eventual access to more fuel-efficient seats could help unit costs, but added capacity may also pressure fares on dense routes. That is a second-order risk for United (UAL), American (AAL), Delta (DAL), Alaska (ALK) and Ryanair (RYAAY); the offset depends on route demand, fleet replacement and whether fuel remains expensive. Near term, the announcement is a positive sentiment catalyst for BA, not evidence of immediate earnings acceleration. Over 1–3 months, monitor production-rate guidance and regulatory posture; over 6–18 months, delivery cadence and quality performance determine whether backlog becomes revenue and cash. A renewed production cap, quality incident, delayed first delivery or weaker customer commitments would falsify the recovery thesis.

Key Decisions for Investors

• BA: Treat the approval as a de-risking event, not a delivery-driven earnings upgrade. Consider a staged long only if the post-announcement price action does not fully capitalize on the milestone; add only on evidence of stable production and an intact 2027 delivery schedule. Reassess on any FAA restriction or delivery slippage.
• Prefer a BA-versus-AIR relative-value watch over an outright Airbus short: certification reduces one competitive uncertainty, but Airbus retains a range/capacity advantage. Initiate only after comparing valuation and order/delivery data, which are not provided here.
• Do not chase airline stocks on prospective fuel savings. For UAL, AAL, DAL, ALK and RYAAY, track aircraft delivery timing, route-level capacity plans and unit-revenue trends; extra seats could lower costs but also dilute fares, while the aircraft benefit is not near-term.
• Near-term alert: verify whether Boeing changes production or delivery guidance, whether airline customers affirm or defer Max 10 commitments, and whether FAA oversight eases further. These are the evidence points needed before sizing a longer-duration BA recovery position.